Board of Directors

Michael Tarantino

Dr. Tarantino has over 25 years of experience in hematology, with eight years as the Founder, Medical Director and President of the Bleeding & Clotting Disorders Institute. For nearly three decades he has devoted his medical career to the management of bleeding and clotting disorders as well as non-malignant hematology disorders. Dr. Tarantino also serves as the medical director of the Anticoagulation Consultation Service at St. Francis Medical Center. Since 2008, Dr. Tarantino is a tenured Professor of Pediatrics and Medicine at the University of Illinois College of Medicine in Peoria and is active in teaching medical students, residents and allied health professionals.

Dr. Tarantino earned a Doctor of Medicine degree from the University of Wisconsin School of Medicine and Public Health in 1987. He then completed a residency in pediatrics from the University of Arizona in 1990 and a fellowship in pediatric hematology and oncology from the University of Wisconsin in 1993.

He is board certified in Pediatric Hematology and Oncology. He is a longstanding member of the Medical and Scientific Advisory Council of the National Hemophilia Foundation and a member of the Medical Advisory Board of the Platelet Disorder Support Association. Dr. Tarantino has served on numerous Boards of Directors, Advisory Boards and Steering Committees including those of the Hemophilia Foundation of Illinois and the acclaimed SIPPET study. In 2012 and 2014, he received a Patient’s Choice Award from Vitals, and he was honored as a physician of the year by the National Hemophilia Foundation from 2012-2013. He was named as one of America’s Top Doctors by Castle Connolly from 2012-2013, and as a Compassionate Doctor from Vitals in 2012. In 2014 the University of Illinois College of Medicine presented him with an Alpha Omega Alpha Teaching Award. In 2005 and 2017 Dr. Tarantino received the Research Excellence Award from the University of Illinois College of Medicine.

Dr. Tarantino has had an active career in clinical and translational research. As a result he has authored or co-authored over 100 peer-reviewed papers, reviews, and book chapters and over 125 scientific abstracts.

RETURN TO BOARD OF DIRECTORS PAGE